Medicare Enrolled

Dr. Michael Zuflacht, M.D.

Neurology · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
303 E QUINCY ST STE 102, San Antonio, TX 78215
2102297242
In practice since 2005 (20 years)
NPI: 1417938507 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zuflacht from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zuflacht? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zuflacht

Dr. Michael Zuflacht is a neurology in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Zuflacht performed 139 Medicare services across 113 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zuflacht received a total of $19,588 from 62 pharmaceutical and/or device companies across 1321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zuflacht is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 139 Medicare services$ $19,588 industry payments

Medicare Practice Summary

Medicare Utilization ↗
139
Medicare services
Bottom 20% in TX for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
113
Unique beneficiaries
$133
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Measurement of brain wave activity (eeg), 61-119 minutes63$241$600
Needle measurement of electrical activity in arm or leg muscles, complete study49$39$160
Nerve conduction, 7-8 studies14$44$400
Nerve conduction, 11-12 studies13$65$500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,588
Total received (2018-2024)
Avg $2,798/year across 7 years
Top 17% in TX for neurology
62
Companies
1,321
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,564 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,778
2023
$4,328
2022
$3,878
2021
$2,640
2020
$2,335
2019
$1,694
2018
$936

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$2,175
UCB, Inc.
$1,684
Novartis Pharmaceuticals Corporation
$1,508
Celgene Corporation
$1,169
Neurocrine Biosciences, Inc.
$1,043
Genentech USA, Inc.
$1,010
Amgen Inc.
$891
ACADIA Pharmaceuticals Inc
$798
Teva Pharmaceuticals USA, Inc.
$783
ABBVIE INC.
$656
Sunovion Pharmaceuticals Inc.
$558
TG THERAPEUTICS, INC.
$484
PFIZER INC.
$454
ARGENX US, INC.
$408
LivaNova USA, Inc.
$405
TG Therapeutics, Inc.
$371
AbbVie Inc.
$355
Alexion Pharmaceuticals, Inc.
$339
GENZYME CORPORATION
$321
Neurelis, Inc.
$312
Biohaven Pharmaceuticals, Inc.
$278
Eisai Inc.
$252
Kyowa Kirin, Inc.
$237
Biohaven Pharmaceutical Holding Company Ltd.
$230
SK Life Science, Inc.
$190
Octapharma USA, Inc.
$180
CATALYST PHARMACEUTICALS, INC.
$178
GE HealthCare
$167
Corium, LLC
$165
Biogen, Inc.
$150
GE HEALTHCARE
$144
GE Healthcare
$141
Janssen Pharmaceuticals, Inc
$131
Supernus Pharmaceuticals, Inc.
$126
Lundbeck LLC
$100
EISAI INC.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$88
Avanir Pharmaceuticals, Inc.
$86
Adamas Pharmaceuticals, Inc.
$79
US WorldMeds, LLC
$79
Avion Pharmaceuticals
$74
Lilly USA, LLC
$72
Allergan, Inc.
$69
CSL Behring
$68
MDD US Operations, LLC
$42
Greenwich Biosciences, Inc.
$42
Abbott Laboratories
$41
Amneal Pharmaceuticals LLC
$41
Acorda Therapeutics, Inc
$37
Sumitomo Pharma America, Inc.
$36
Bausch Health US, LLC
$34
IMPEL PHARMACEUTICALS INC.
$33
Otter Pharmaceuticals, LLC
$25
Otsuka Pharmaceutical Development & Commercialization, Inc.
$25
GRT US Holding, Inc.
$22
Promius Pharma LLC
$19
SANOFI PASTEUR INC.
$17
Medtronic, Inc.
$17
Aprecia Pharmaceuticals, LLC
$14
JAZZ PHARMACEUTICALS INC.
$13
AQUESTIVE THERAPEUTICS, INC.
$12
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 27.4% of total payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BRIUMVI · Briviact · COMIRNATY · Confirm Rx · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · EVENITY · Enbrel · Enspryng · Epidiolex · FIRDAPSE · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gocovri · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OXTELLAR XR · Ocrevus · Ongentys · Otezla · PANZYGA · PERCEPT PC BRAINSENSE · Ponvory · QULIPTA · Qutenza · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SYMPAZAN · Soliris · Spritam · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $14,092 per 100 Medicare services performed
Looking for a neurology in San Antonio?
Compare neurologys in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
116
Per 100K population
5.7
County median income
$70,571
Nearest hospital
BAPTIST MEDICAL CENTER
1.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Zuflacht is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 17%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Zuflacht experienced with measurement of brain wave activity (eeg), 61-119 minutes?
Based on Medicare claims data, Dr. Zuflacht performed 63 measurement of brain wave activity (eeg), 61-119 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zuflacht receive payments from pharmaceutical companies?
Yes. Dr. Zuflacht received a total of $19,588 from 62 companies across 1,321 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zuflacht's costs compare to other neurologys in San Antonio?
Dr. Zuflacht's average Medicare payment per service is $133. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zuflacht) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →